Core IM | Internal Medicine Podcast cover image

#85 Dual Antiplatelet Therapy: 5 Pearls Segment

Core IM | Internal Medicine Podcast

00:00

Is Aspirant a Better Blood Thinner Than Aspern?

There is a lot of data about the fact that we may be able to drop aspiron, which hasn't fully come into clinical practice or changed guide lines yet. Aspern's an indiscriminate cox inhibitor, blocking prostec land in production. And so they both inhibit platelets, but aspern also has that second bleeding hit risk because it hurts the g i mucosa. You'll see the suggestion in capri that clopitege actually has a lower bleeding wrist than aspirat,. It was a 325 milligram dose instead of 81 milligrams.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app